Delcath

Delcath to trial Hepzato drug device combo in colorectal cancer
Clinical Trials Arena
Tue, 12/3/24 - 09:38 am
Delcath
Hepzato
colorectal cancer
drug-device combos
Delcath Gets FDA Approval for Cancer Drug-Device Combo 10 Years After Rejection
BioSpace
Wed, 08/16/23 - 10:21 am
Delcath
drug-device combos
FDA
Hepzato
uveal melanoma
Greater Fools Love Delcath, Zalicus On Orphan Drug Derpitude
TheStreet.com
Wed, 10/2/13 - 02:38 pm
Delcath
Zalicus
orphan drugs
Chemosat
liver cancer
Delcath dives again on final FDA denial of liver cancer treatment
Mass Device
Mon, 09/16/13 - 11:19 am
Delcath
FDA
liver cancer
devices
Melblez
2013 FDA Drug Approval Calendar
TheStreet.com
Tue, 05/21/13 - 12:05 pm
drug approvals
GSK
Dolutegravir
Trametenib
Auxilium
Xiaflex
Delcath
Melblez
Seattle Genetics
Adcetris
Antares
Otrexup
Amag Pharmaceuticals
Feraheme
Cubist Pharmaceuticals
Entereg
Gilead
sofosbuvir
Amarin
Vascepa
Merck
suvorexant
Valeant Pharmaceuticals
efinaconazole
Depomed
Sefelsa
Zogenix
Zohydro
dabrafenib
tivozanib
Aveo Pharmaceuticals
FDA advisers recommend against Delcath's cancer therapy
Reuters
Fri, 05/3/13 - 08:59 am
FDA
advisory panels
Delcath
Melblez
Aveo, Delcath FDA Panel Live Blog
TheStreet.com
Thu, 05/2/13 - 10:52 am
FDA
advisory panels
tivozanib
Delcath
Aveo Oncology
kidney cancer
Melblez
Delcath: A Cancer Treatment Biotech With Good Short And Long-Term Potential
Seeking Alpha
Mon, 04/22/13 - 11:22 am
Delcath
liver cancer
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tue, 04/2/13 - 10:58 am
Arena Pharmaceuticals
Zogenix
Delcath
Aveo Pharmaceutical
Vivus
Titan Pharmaceuticals
Bristol-Myers Squibb
Merck
Gilead
AbbVie
Amarin
Achillion
Sangamo BioSciences
Raptor Pharmaceuticals
Vertex Pharmaceuticals
NewLink Genetics
AstraZeneca
Rigel
Depomed
Biogen Idec
Sucampo
Dendreon
Valeant Pharmaceuticals
GSK
Aegerion
2 Cancer Biotechs With Upcoming FDA Approval Decisions In 2013
Seeking Alpha
Sat, 03/23/13 - 09:00 am
Delcath
Aveo Pharmaceutical
tivozanib
renal cell carcinoma
Chemosat
melanoma
metastatic melanoma
Best And Worst FDA Drug Approval Stocks of 2013
TheStreet.com
Tue, 03/12/13 - 11:45 am
Arena Pharmaceuticals
Sarepta
Ziopharm
Delcath
Aveo Pharmaceutical
United Therapeutics
AP Pharma
Titan Pharmaceuticals
Navidea Biopharmaceuticals
Biogen Idec
Raptor Pharmaceuticals
Delcath Systems: Bullish On Melblez FDA Panel Vote And Subsequent Approval
Seeking Alpha
Fri, 03/8/13 - 11:10 am
Delcath
FDA
advisory panels
Melblez
ocular melanoma
Is Delcath The Post-Celsion Play On Liver Cancer?
Seeking Alpha
Mon, 02/4/13 - 12:18 pm
Delcath
liver cancer
Celsion
Chemosat
Roche Leads Pack for Upcoming FDA Approvals
Motley Fool
Wed, 01/9/13 - 12:20 pm
FDA
drug approvals
Roche
T-DM1
Aveo
Delcath
Navidea Biopharmaceuticals
Lymphoseek
tivozanib
chemostat
Cancer: Delcath lands expanded CE Mark for organ-isolating chemo treatment
Tue, 10/23/12 - 11:11 pm
cancer
Delcath
CE Mark
chemo
Delcath files new FDA application for chemo drug-device combination
Thu, 08/16/12 - 10:50 pm
Delcath
FDA
cancer
BIO CEO Confab Live Blog: Day 2
TheStreet.com
Tue, 02/14/12 - 11:29 am
BIO CEO Conference
Pfizer
Indenix
Keryx
Delcath
Oncothyreon
Acorda Therapeutics
Human Genome Sciences
Gilead
Delcath's ChemoSat goes another round with the FDA
Fri, 10/28/11 - 06:21 pm
Delcath
chemotherapy
FDA
Delcath taps Miao as CFO
Mon, 09/26/11 - 11:00 pm
Delcath
Management
CFO
Cancer therapy device maker Delcath drops hard on inconclusive trial results
Tue, 09/6/11 - 10:38 pm
cancer
therapy
Delcath
trial

Pages